849022-03-3 Usage
Uses
Used in Pharmaceutical Synthesis:
Methyl 4-hydroxy-8-methylquinoline-2-carboxylate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of drugs with diverse therapeutic applications.
Used in Agrochemical Production:
Methyl 4-hydroxy-8-methylquinoline-2-carboxylate is also utilized as an intermediate in the production of agrochemicals, where it plays a role in the creation of substances designed to improve crop yields and protect plants from pests and diseases.
Used in Skincare and Topical Treatments:
Methyl 4-hydroxy-8-methylquinoline-2-carboxylate is used as an active ingredient in skincare and topical treatments due to its potent antioxidant and anti-inflammatory properties, which can help to protect and soothe the skin.
Used in Neurodegenerative Disease Research:
In the medical and scientific fields, Methyl 4-hydroxy-8-methylquinoline-2-carboxylate is used as a subject of research for its potential application in the treatment of neurodegenerative diseases, given its demonstrated properties.
Used in Cancer Treatment Studies:
Methyl 4-hydroxy-8-methylquinoline-2-carboxylate is used in cancer research as a potential therapeutic agent, with ongoing studies exploring its effectiveness against various types of cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 849022-03-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,0,2 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 849022-03:
(8*8)+(7*4)+(6*9)+(5*0)+(4*2)+(3*2)+(2*0)+(1*3)=163
163 % 10 = 3
So 849022-03-3 is a valid CAS Registry Number.
849022-03-3Relevant articles and documents
2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS
-
Page 43, (2010/02/07)
Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.
Platelet adenosine diphosphate receptor antagonists
-
, (2008/06/13)
Compounds of the following formula (I): where a, b, R1, R2, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, met
